Favaro, Marco http://orcid.org/0000-0002-3502-8332
Mattina, Walter
Pistoia, Enrico Salvatore
Gaziano, Roberta http://orcid.org/0000-0003-1970-2670
Di Francesco, Paolo
Middleton, Simon
D’Angelo, Silvia
Altarozzi, Tullio
Fontana, Carla http://orcid.org/0000-0003-2198-1947
Funding for this research was provided by:
This study beneficed of financial support by Adaltis s.r.l. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication
Article History
Received: 20 April 2021
Accepted: 27 August 2021
First Online: 23 September 2021
Competing interests
: Carla Fontana has received a research grant by Quintiles/Angelini. Advisory Board: Angelini, Pfizer. Marco Favaro has received a research grant by Alifax R&D and Adaltis s.r.l. Walter Mattina, Simon Middleton, Silvia D’Angelo and Tullio Altarozzi are employed in Adaltis. The remaining authors have no competing interests.